Related references
Note: Only part of the references are listed.The role of PLA2R antibody monitoring: what we know and what we do not know
Pierre Ronco et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
Agnes Trautmann et al.
PEDIATRIC NEPHROLOGY (2023)
Trends in the Global Burden of Glomerulonephritis
Bhadran Bose et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2023)
Discovery of Autoantibodies Targeting Nephrin in Minimal Change Disease Supports a Novel Autoimmune Etiology
Andrew J. B. Watts et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2022)
B-Cell Dysregulation in Idiopathic Nephrotic Syndrome: What We Know and What We Need to Discover
Manuela Colucci et al.
FRONTIERS IN IMMUNOLOGY (2022)
New and Old Anti-CD20 Monoclonal Antibodies for Nephrotic Syndrome. Where We Are?
Biswanath Basu et al.
FRONTIERS IN IMMUNOLOGY (2022)
Belimumab for the treatment of children with frequently relapsing nephrotic syndrome: the BELNEPH study
Marina Vivarelli et al.
PEDIATRIC NEPHROLOGY (2022)
The Role of Anti-PLA2R and Anti-THSD7A Antibodies in the Pathogenesis and Diagnostics of Primary Membranous Nephropathy: A Review of Current Knowledge for Clinical Practice
Iwona Smarz-Widelska et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)
Therapies for Membranous Nephropathy: A Tale From the Old and New Millennia
Francesco Scolari et al.
FRONTIERS IN IMMUNOLOGY (2022)
Novel Biomarkers in Membranous Nephropathy
Qiuying Liu et al.
FRONTIERS IN IMMUNOLOGY (2022)
Structural Inequities and Barriers to Accessing Kidney Healthcare Services in the United States: A Focus on Uninsured and Undocumented Children and Young Adults
Franca M. Iorember et al.
FRONTIERS IN PEDIATRICS (2022)
The landscape of T and B lymphocytes interaction and synergistic effects of Th1 and Th2 type response in the involved tissue of IgG4-RD revealed by single cell transcriptome analysis
Shaozhe Cai et al.
JOURNAL OF AUTOIMMUNITY (2022)
Efficacy and safety of 12 immunosuppressive agents for idiopathic membranous nephropathy in adults: A pairwise and network meta-analysis
Jiarong Liu et al.
FRONTIERS IN PHARMACOLOGY (2022)
Epidemiological characteristics and pathological changes of primary glomerular diseases
Yan Li et al.
PLOS ONE (2022)
The Health Economic Impact of Nephrotic Syndrome in the United States
Christine A. Simon et al.
KIDNEY360 (2022)
Immunosuppression therapy for idiopathic membranous nephropathy: systematic review with network meta-analysis
Bhadran Bose et al.
JOURNAL OF NEPHROLOGY (2022)
A digest of the Evidence-Based Clinical Practice Guideline for Nephrotic Syndrome 2020
Takehiko Wada et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2021)
Membranous nephropathy
Pierre Ronco et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Efficacy and cost of different treatment in patients with idiopathic membranous nephropathy: A network meta-analysis and cost-effectiveness analysis
Pinyuan Dai et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
Autoantibodies in the Diagnosis, Monitoring, and Treatment of Membranous Nephropathy
Vladimir Tesar et al.
FRONTIERS IN IMMUNOLOGY (2021)
Pediatric idiopathic steroid-sensitive nephrotic syndrome: diagnosis and therapy -short version of the updated German best practice guideline (S2e) - AWMF register no. 166-001, 6/2020
Rasmus Ehren et al.
PEDIATRIC NEPHROLOGY (2021)
Steroid Sensitive Nephrotic Syndrome: Revised Guidelines
Aditi Sinha et al.
INDIAN PEDIATRICS (2021)
Efficacy and safety of rituximab in the treatment of membranous nephropathy A systematic review and meta-analysis
WanJun Lu et al.
MEDICINE (2020)
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome
Agnes Trautmann et al.
PEDIATRIC NEPHROLOGY (2020)
Belimumab and Rituximab in Systemic Lupus Erythematosus: A Tale of Two B Cell-Targeting Agents
Leanna M. Wise et al.
Frontiers in Medicine (2020)
Inequities in curative health-care utilization among the adult population (20-59 years) in India: A comparative analysis of NSS 71st (2014) and 75th (2017-18) rounds
Shreya Banerjee et al.
PLOS ONE (2020)
Levamisole-induced vasculopathy: A systematic review
Anais Dartevel et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2019)
Efficacy and acceptability of immunosuppressive agents for pediatric frequently-relapsing and steroid-dependent nephrotic syndrome A network meta-analysis of randomized controlled trials
Liping Tan et al.
MEDICINE (2019)
Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation
Nicholas J. A. Webb et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy
F. C. Fervenza et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Comparative efficacy of 13 immunosuppressive agents for idiopathic membranous nephropathy in adults with nephrotic syndrome: a systematic review and network meta-analysis
Qiyan Zheng et al.
BMJ OPEN (2019)
Efficacy and safety of mycophenolate mofetil versus levamisole in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial
Aditi Sinha et al.
KIDNEY INTERNATIONAL (2019)
Persistent CD-19 depletion by rituximab is cost-effective in maintaining remission in calcineurin-inhibitor dependent podocytopathy
Raja Ramachandran et al.
NEPHROLOGY (2019)
Socioeconomic inequality in life expectancy in India
Miqdad Asaria et al.
BMJ GLOBAL HEALTH (2019)
Cocaine/levamisole-associated autoimmune syndrome: a disease of neutrophil-mediated autoimmunity
Michael J. Cascio et al.
CURRENT OPINION IN HEMATOLOGY (2018)
NEPHRUTIX: A randomized, double-blind, placebo vs Rituximab-controlled trial assessing T-cell subset changes in Minimal Change Nephrotic Syndrome
Ahmed Boumediene et al.
JOURNAL OF AUTOIMMUNITY (2018)
Idiopathic nephrotic syndrome in children
Damien G. Noone et al.
LANCET (2018)
Rituximab versus the modified Ponticelli regimen in the treatment of primary membranous nephropathy: a Health Economic Model
Patrick Hamilton et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
Mycophenolate mofetil for sustained remission in nephrotic syndrome
Uwe Querfeld et al.
PEDIATRIC NEPHROLOGY (2018)
Immunosuppressive therapy for steroid-resistant nephrotic syndrome: a Bayesian network meta-analysis of randomized controlled studies
Xinxin Jiang et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2018)
Long-term efficacy and safety of common steroid-sparing agents in idiopathic nephrotic children
Biswanath Basu et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2017)
Comparison of second-line immunosuppressants for childhood refractory nephrotic syndrome: a systematic review and network meta-analysis
Hai-Dong Fu et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2017)
Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up
Karine Dahan et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Treatment of membranous nephropathy: time for a paradigm shift
Piero Ruggenenti et al.
NATURE REVIEWS NEPHROLOGY (2017)
Increasing prevalence of membranous nephropathy in patients with primary glomerular diseases: A cross-sectional study in China
Lijun Tang et al.
NEPHROLOGY (2017)
Efficacy and safety of immunosuppressive medications for steroid-resistant nephrotic syndrome in children: a systematic review and network meta-analysis
Shaojun Li et al.
ONCOTARGET (2017)
Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis
Song Ren et al.
PLOS ONE (2017)
Cost-Effectiveness of Administering Rituximab for Steroid-Dependent Nephrotic Syndrome and Frequently Relapsing Nephrotic Syndrome: A Preliminary Study in Japan
Tomoyuki Takura et al.
SCIENTIFIC REPORTS (2017)
Primary glomerulonephritides
Juergen Floege et al.
LANCET (2016)
Calcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent models
Xiujin Shen et al.
SCIENTIFIC REPORTS (2016)
Calcineurin inhibitors dampen humoral immunity by acting directly on naive B cells
R. De Bruyne et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2015)
Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: medical therapy
Kenji Ishikura et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2015)
Levamisole in steroid-sensitive nephrotic syndrome: usefulness in adult patients and laboratory insights into mechanisms of action via direct action on the kidney podocyte
Lulu Jiang et al.
CLINICAL SCIENCE (2015)
Efficacy of levamisole in children with frequently relapsing and steroid-dependent nephrotic syndrome
Sudha Ekambaram et al.
INDIAN PEDIATRICS (2014)
Bortezomib therapy for nephrotic syndrome due to idiopathic membranous nephropathy
Choli Hartono et al.
JOURNAL OF NEPHROLOGY (2014)
Rituximab in Steroid-Dependent or Frequently Relapsing Idiopathic Nephrotic Syndrome
Piero Ruggenenti et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial
Kazumoto Iijima et al.
LANCET (2014)
Thrombospondin Type-1 Domain-Containing 7A in Idiopathic Membranous Nephropathy
Nicola M. Tomas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Randomized comparative trial of mizoribine versus mycophenolate mofetil in combination with tacrolimus for living donor renal transplantation
Shiro Takahara et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2013)
Effect of single-dose rituximab on steroid-dependent minimal-change nephrotic syndrome in adults
Takashi Takei et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Renal disease in the elderly and the very elderly Japanese: analysis of the Japan Renal Biopsy Registry (J-RBR)
Hitoshi Yokoyama et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2012)
Th17/Treg imbalance in adult patients with minimal change nephrotic syndrome
Li-li Liu et al.
CLINICAL IMMUNOLOGY (2011)
Calcineurin inhibitors affect B cell antibody responses indirectly by interfering with T cell help
S. Heidt et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Behavioural abnormalities in children with nephrotic syndrome
Om P. Mishra et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Effector and regulatory B cells: modulators of CD4+ T cell immunity
Frances E. Lund et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Oral Administration of 1,4-Aryl-2-mercaptoimidazole Inhibits T-Cell Proliferation and Reduces Clinical Severity in the Murine Experimental Autoimmune Encephalomyelitis Model
Eun Joo Jung et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
M-Type Phospholipase A(sub 2) Receptor as Target Antigen in Idiopathic Membranous Nephropathy.
Laurence H. Beck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Increased nitric oxide production by T- and B-cells in idiopathic nephrotic syndrome
Anna Iharada et al.
PEDIATRIC NEPHROLOGY (2009)
The prevalence of Th17 cells and FOXP3 regulate T cells (Treg) in children with primary nephrotic syndrome
Xiao Shan Shao et al.
PEDIATRIC NEPHROLOGY (2009)
T follicular helper (T-FH) cells in normal and dysregulated immune responses
Cecile King et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
Children with steroid-sensitive nephrotic syndrome come of age:: Long-term outcome
EM Rüth et al.
JOURNAL OF PEDIATRICS (2005)
Long-term linear growth of children with severe steroid-responsive nephrotic syndrome
F Emma et al.
PEDIATRIC NEPHROLOGY (2003)
Th1/Th2 balance and CD45-positive T cell subsets in primary nephrotic syndrome
J Stachowski et al.
PEDIATRIC NEPHROLOGY (2000)
A multicenter trial of mizoribine compared with placebo in children with frequently relapsing nephrotic syndrome
K Yoshioka et al.
KIDNEY INTERNATIONAL (2000)
Share Paper
